APA

Flinn I. W., Panayiotidis P., Afanasyev B., Janssens A., Grosicki S., Homenda W., Smolej L., Kuliczkowski K., Doubek M., Domnikova N., West S. L., Chang C., Barker A. M., Gupta I. V., Wright O. J. & Offner F. (20170717). A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. : American journal of hematology.

Chicago

Flinn Ian W, Panayiotidis Panayiotis, Afanasyev Boris, Janssens Ann, Grosicki Sebastian, Homenda Wojciech, Smolej Lukas, Kuliczkowski Kazimierz, Doubek Michael, Domnikova Natalia, West Sarah L, Chang Chai-Ni, Barker Alison M, Gupta Ira V, Wright Oliver J and Offner Fritz. 20170717. A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. : American journal of hematology.

Harvard

Flinn I. W., Panayiotidis P., Afanasyev B., Janssens A., Grosicki S., Homenda W., Smolej L., Kuliczkowski K., Doubek M., Domnikova N., West S. L., Chang C., Barker A. M., Gupta I. V., Wright O. J. and Offner F. (20170717). A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. : American journal of hematology.

MLA

Flinn Ian W, Panayiotidis Panayiotis, Afanasyev Boris, Janssens Ann, Grosicki Sebastian, Homenda Wojciech, Smolej Lukas, Kuliczkowski Kazimierz, Doubek Michael, Domnikova Natalia, West Sarah L, Chang Chai-Ni, Barker Alison M, Gupta Ira V, Wright Oliver J and Offner Fritz. A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. : American journal of hematology. 20170717.